Literature DB >> 1382905

Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.

M R Capobianchi1, S Fais, M C Di Paolo, D Agostini, P Paoluzi, F Pallone, F Dianzani.   

Abstract

Whether inflammatory bowel diseases (IBD) can be classified as autoimmune disorders is not established. Since circulating acid-labile interferon-alpha (IFN-alpha) is believed to reflect autoimmune reactions, we tested sera from two groups of IBD patients for the presence of circulating IFN. No detectable IFN was found in 51 serum samples of IBD patients. Furthermore, in no serum sample of IBD patients were neutralizing anti-IFN antibodies found. In contrast, acid-labile IFN-alpha was present in sera from 21/52 HIV-infected and from 6/14 systemic lupus erythematosus patients. These observations provide evidence that IBD differs from systemic autoimmune disorders, at least for the presence of circulating IFN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382905      PMCID: PMC1554556          DOI: 10.1111/j.1365-2249.1992.tb05836.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; R P MacDermott; A Raedler; R Pinnau; M J Bertovich; G S Nash
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

3.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Natural antibodies to IFN-gamma in man and their increase during viral infection.

Authors:  A Caruso; C Bonfanti; D Colombrita; M De Francesco; C De Rango; I Foresti; F Gargiulo; R Gonzales; G Gribaudo; S Landolfo
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

5.  Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin.

Authors:  G J Stanton; M P Langford; F Dianzani
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease.

Authors:  F Pallone; P M Matricardi; O Squarcia; S Fais; S Le Moli; M Boirivant; P Paoluzi; R D'Amelio
Journal:  J Clin Lab Immunol       Date:  1986-04

7.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

9.  Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.

Authors:  S Fais; M R Capobianchi; F Pallone; P Di Marco; M Boirivant; F Dianzani; A Torsoli
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

10.  Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.

Authors:  G Antonelli; M Currenti; O Turriziani; F Dianzani
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

View more
  2 in total

1.  Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models.

Authors:  Ben Vainer; Susanne Sørensen; Jakob Seidelin; Ole Haagen Nielsen; Thomas Horn
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

2.  Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.

Authors:  Olga Y Korolkova; Jeremy N Myers; Samuel T Pellom; Li Wang; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2015-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.